Karuna Therapeutics Inc

NASDAQ:KRTX  
118.97
-7.67 (-6.06%)
Products, Strategic Combinations

Karuna Therapeutics And Zai Lab Announce Strategic Collaboration For Development, Manufacturing, And Commercialization Of KarXT In Greater China

Published: 11/09/2021 12:08 GMT
Karuna Therapeutics Inc (KRTX) - Karuna Therapeutics and Zai Lab Announce Strategic Collaboration for Development, Manufacturing, and Commercialization of Karxt in Greater China.
Karuna Therapeutics Inc - Zai Lab Obtains Exclusive Rights to Develop and Commercialize Karxt in Greater China.
Karuna Therapeutics Inc - Karuna to Receive Upfront Cash Payment of $35 Million.
Karuna Therapeutics Inc - Eligible to Receive Up to an Additional $80 Million in Development and Regulatory Milestones.
Karuna Therapeutics Inc - Also Eligible to Receive Up to $72 Million in Sales Milestones and Low-double-digit to High-teens Tiered Royalties.